ATE279876T1 - Verfahren zur feststellung von reperfusion nach thrombolytischer therapie - Google Patents

Verfahren zur feststellung von reperfusion nach thrombolytischer therapie

Info

Publication number
ATE279876T1
ATE279876T1 AT96928200T AT96928200T ATE279876T1 AT E279876 T1 ATE279876 T1 AT E279876T1 AT 96928200 T AT96928200 T AT 96928200T AT 96928200 T AT96928200 T AT 96928200T AT E279876 T1 ATE279876 T1 AT E279876T1
Authority
AT
Austria
Prior art keywords
thrombolytic therapy
onset
patient
variable
predetermined time
Prior art date
Application number
AT96928200T
Other languages
English (en)
Inventor
E Magnus Ohman
Robert H Christenson
Robert M Califf
Mary Ann O'hanesian
Kristina N Sigmon
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Application granted granted Critical
Publication of ATE279876T1 publication Critical patent/ATE279876T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/50—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving creatine phosphokinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Branch Pipes, Bends, And The Like (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT96928200T 1995-08-17 1996-08-16 Verfahren zur feststellung von reperfusion nach thrombolytischer therapie ATE279876T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51615995A 1995-08-17 1995-08-17
PCT/US1996/013264 WO1997006725A1 (en) 1995-08-17 1996-08-16 Method of assessing reperfusion after thrombolytic therapy

Publications (1)

Publication Number Publication Date
ATE279876T1 true ATE279876T1 (de) 2004-11-15

Family

ID=24054387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928200T ATE279876T1 (de) 1995-08-17 1996-08-16 Verfahren zur feststellung von reperfusion nach thrombolytischer therapie

Country Status (6)

Country Link
US (1) US6033364A (de)
EP (1) EP0869733B1 (de)
AT (1) ATE279876T1 (de)
AU (1) AU6775996A (de)
DE (1) DE69633681T2 (de)
WO (1) WO1997006725A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6662114B1 (en) * 1999-08-23 2003-12-09 Duke University Methods for evaluating therapies and predicting clinical outcome related to coronary conditions
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
US20060253300A1 (en) * 2005-05-03 2006-11-09 Somberg Benjamin L System and method for managing patient triage in an automated patient management system
SE532103C2 (sv) * 2006-12-12 2009-10-27 Knut Johansen Metod för att bestämma hälsostatus från analyter i vätskeprover
US20090292213A1 (en) * 2008-05-21 2009-11-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20100036263A1 (en) * 2008-08-07 2010-02-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090163856A1 (en) * 2007-12-19 2009-06-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Treatment indications informed by a prior implant information
US20090292214A1 (en) * 2008-05-22 2009-11-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US8636670B2 (en) * 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US20090287120A1 (en) 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
US5246001A (en) * 1992-03-31 1993-09-21 Duke University Method of assessing reperfusion after thrombolytic therapy

Also Published As

Publication number Publication date
US6033364A (en) 2000-03-07
EP0869733B1 (de) 2004-10-20
EP0869733A1 (de) 1998-10-14
WO1997006725A1 (en) 1997-02-27
AU6775996A (en) 1997-03-12
DE69633681T2 (de) 2005-11-17
DE69633681D1 (de) 2004-11-25
EP0869733A4 (de) 1998-10-14

Similar Documents

Publication Publication Date Title
DE69633681D1 (de) Verfahren zur feststellung von reperfusion nach thrombolytischer therapie
DE68921948D1 (de) System und Verfahren zur Erkennung und Behandlung von ventrikulären Arrhythmien.
DE69720274D1 (de) Anzeige des auftretens von herzschlägen
DE69130289D1 (de) Therapeutische verwendung von actin-bindenden verbindungen
DE69623234D1 (de) Systeme und methoden zur vorherbestimmung von parametern bei der behandlung von blut
DE60011274D1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
EP0685852A3 (de) Speichersystem und Verfahren zu seinem Gebrauch.
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
DE69724855D1 (de) Verfahren, Datenspeicher und System zur automatischen Veränderung von objektorientierten Computerprogrammen, welche Zugriff und Veränderung von persistent gespeicherten Objekten aufweisen.
ATE168135T1 (de) Diagnose von retinoblastoma
Fava et al. Absence of circadian variation in the onset of acute myocardial infarction in diabetic subjects
PT948604E (pt) Produtos e metodos relacionados com pyk2
Apple et al. Analyses of creatine kinase isoenzymes and isoforms in serum to detect reperfusion after acute myocardial infarction.
ES2072490T3 (es) Procedimiento para la pasteurizacion de la proteina tisular pp4.
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
DE3864710D1 (de) Verfahren zur bestimmung von hochmolekularen hyaluronsaeure.
JPS5932443B2 (ja) トロンビン阻止物質、その製造方法及び該物質を含有するトロンビン阻止用薬剤組成物
Alkjaersig et al. Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disorders
Terada et al. Hemorrhagic infarction after vasospasm due to ruptured cerebral aneurysm
DE69636041D1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
DE69734890D1 (de) Rdgb-proteine
Ouyang et al. The effects of the purified thrombin-like and anticoagulant principles of Agkistrodon acutus venom on blood coagulation in vivo
ATE148233T1 (de) Verfahren zur bestimmung von thrombose verursachenden lupus-anticoagulant-antikörpern
DE20213920U1 (de) Diagnostikum zum Nachweis der den von Willebrand-Faktorspaltenden Aktivität von ADAMTS13
ATE235058T1 (de) Screening von wirkstoffen zur behandlung von alzheimer-krankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties